Alterations of p16INK4a tumour suppressor gene in mucoepidermoid carcinoma of the salivary glands

International Journal of Oral and Maxillofacial Surgery

Volumn 36, Issue 4, 2007, Pages 350-353

  Guo, X L ^a   Sun, S Z ^a   Wang, W X ^a   Wei, F C ^b   Yu, H B ^a   Ma, B L ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

deletion; DNA methylation; mucoepidermoid carcinoma; mutation; p16INK4a; salivary gland

Indexed keywords

PROTEIN P16INK4A;

ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EXON; FEMALE; GENE DELETION; GENE INACTIVATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MALE; POINT MUTATION; PROMOTER REGION; SALIVARY GLAND CARCINOMA; SCHOOL CHILD; TUMOR SUPPRESSOR GENE; CHILD; GENE EXPRESSION REGULATION; GENETICS; HOMOZYGOTE; METHYLATION; MIDDLE AGED; MUTATION; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SALIVARY GLAND; SALIVARY GLAND TUMOR; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CARCINOMA, MUCOEPIDERMOID; CHILD; EXONS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; HOMOZYGOTE; HUMANS; MALE; METHYLATION; MIDDLE AGED; MUTATION; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS;

EID: 33847065782     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2006.11.004     Document Type: Article

References (23)

1. Clode A.L., Fonseca I., Santos J.R., and Soares J. Mucoepidermoid carcinoma of salivary glands: a reappraisal of the influence of tumour differentiation on prognosis. J Surg Oncol 46 (1991) 100-106
2. Esteller M., and Herman J.G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 196 (2002) 1-7
3. Esteller M., Sanchez-Cespedes M., and Rosell R. Detection of aberrant promoter hypermethylation of tumour suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59 (1999) 67-70
4. Etges A., Nunes F.D., Ribeiro K.C.B., and Araújo V.C. Immunohistochemical expression of retinoblastoma pathway proteins in normal salivary glands and in salivary gland tumours. Oral Oncol 40 (2004) 326-331
5. Gonzalez M.V., Pello M.F., Lopez-Larrea C., Menendez M.J., and Coto M. Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma. J Clin Pathol 50 (1997) 509-512
6. Greene F.L., Page D.L., Fleming I.D., Fritz A.G., Balch C.M., and Haller D.G. AJCC cancer staging manual. 6th edn. (2002), Springer-Verlag, New York, NY pp. 81-87
7. Guzzo M., Andreola S., Sirizzotti G., and Cantu G. Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan. Ann Surg Oncol 9 (2002) 688-695
8. Handra-Luca A., Bilal H., Bertr J.C., and Fouret P. Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumour behaviour and tumour cell proliferation. Am J Pathol 163 (2003) 957-967
9. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93 (1996) 9821-9826
10. Hsu L.S., Lee H.C., Chau G.Y., Yin P.H., Chi C.W., and Lui W.Y. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Oncol Rep 15 (2006) 507-511
11. Johns M.E., and Goldsmith M.M. Incidence, diagnosis, and classification of salivary gland tumours. Part 1. Oncology (Williston Park) 3 (1989) 47-56
12. Kishi M., Nakamura M., Nishimine M., Ikuta M., Kirita T., and Konishi N. Genetic and epigenetic profiles for multiple genes in salivary gland carcinomas. Oral Oncol 41 (2005) 161-169
13. Kokemueller H., Brueggemann N., Swennen G., and Eckardt A. Mucoepidermoid carcinoma of the salivary glands-clinical review of 42 cases. Oral Oncol 41 (2005) 3-10
14. Monoo K., Sageshima M., Ito E., Nishihira S., and Ishikawa K. Histopathological grading and clinical features of patients with mucoepidermoid carcinoma of the salivary glands. Nippon Jibiinkoka Gakkai Kaiho 106 (2003) 192-198
15. Nakahara Y., Shintani S., Mihara M., Ueyama Y., and Matsumura T. High frequency of homozygous deletion and methylation of p16INK4A gene in oral squamous cell carcinomas. Cancer Lett 163 (2001) 221-228
16. Nishimine M., Nakamura M., Kishi M., Okamoto M., Shimada K., and Ishida E. Alterations of p14ARF and p16INK4a genes in salivary gland carcinomas. Oncol Rep 10 (2003) 555-560
17. Ogi K., Toyota M., Ohe-Toyota M., Tanaka N., Noguchi M., and Sonoda T. Aberrant methylation of multiple genes and clincopathological features in oral squamous cell carcinoma. Clin Cancer Res 8 (2002) 3164-3171
18. Reed A.L., Califano J., Cairns P., Westra H.W., Jones M.R., and Koch W. High frequency p16 (CDKN2/MTS1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56 (1996) 3630-3633
19. 6-methylguanine-DNA-methyltransferase and death-associated protein kinase in tumours and saliva of head and neck cancer patients. Cancer Res 61 (2001) 939-942
20. INK4A genes is a frequent event in human oral squamous cell carcinomas. Oral Oncol 37 (2001) 498-504
21. Tsou J.A., Shen L.Y., Siegmund K.D., Long T.I., Laird P.W., Seneviratne C.K., Koss M.N., Pass H.I., Hagen J.A., and Laird-Offringa I.A. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumour lung. Lung Cancer 47 (2005) 193-204
22. Zhang S.Y., Klein-Szanto A.J.P., Sauter E.R., Shafamko M., Mitsunage S., and Nobori S. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumours of head and neck. Cancer Res 54 (1994) 5050-5053
23. Zhao Y., Zhang S., Fu B., and Xiao C. Abnormalities of tumour suppressor gene P16 and P15 in primary maxillofacial squamous cell carcinomas. Cancer Genet Cytogenet 112 (1999) 26-33